Biotts claims a first with insulin delivery across skin
pharmaphorum
MAY 1, 2024
Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.
pharmaphorum
MAY 1, 2024
Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.
BioPharma Reporter
NOVEMBER 21, 2022
Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 29, 2022
For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. In absolute terms, there were 0.73
XTalks
SEPTEMBER 23, 2020
Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.
XTalks
JULY 24, 2024
Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drug delivery service for consumers. In 2023, it introduced RxPass , a prescription drug program that offers common drugs for a flat fee of $5. According to Statista , the global online pharmacy market is predicted to hit $82.42
Camargo
OCTOBER 14, 2020
Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes.
XTalks
OCTOBER 7, 2024
The US Food and Drug Administration (FDA) has issued a Class I label for the recall of Medtronic’s MiniMed insulin pumps. The devices are used to regulate blood glucose levels by delivering precise amounts of insulin based on readings from an integrated continuous glucose monitor (CGM).
Let's personalize your content